Unichem Labs gets EIR from USFDA for Roha API facility

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-08-27 05:52 GMT   |   Update On 2025-08-27 05:52 GMT
Advertisement

MumbaiUnichem Labs has announced that the company has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) facility in Roha.

The inspection was conducted by the USFDA from 16th June 2025 to 20th June 2025. Following the inspection, the company had received three observations for the facility.

The USFDA has now classified the inspection as Voluntary Action Initiated (VAI) and issued the EIR.

VAI  means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action

Read also: Unichem Labs Roha facility gets 3 USFDA observations

Headquartered in Mumbai, Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. The company was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.

Read also: Sandip Ghume to resign as Unichem Labs Deputy CFO, Key Managerial Personnel

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News